Iproniazid Phosphate

CAS No. 305-33-9

Iproniazid Phosphate( AI3-62177, Iproniazid dihydrogen phosphate, Iproniazid phosphate )

Catalog No. M13971 CAS No. 305-33-9

Iproniazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 27 In Stock
100MG 42 In Stock
200MG 61 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Iproniazid Phosphate
  • Note
    Research use only, not for human use.
  • Brief Description
    Iproniazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class.
  • Description
    Iproniazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class. It was discontinued in most of the world in the 1960s, but remained in use in France up until fairly recently.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AI3-62177, Iproniazid dihydrogen phosphate, Iproniazid phosphate
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    MAO
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    305-33-9
  • Formula Weight
    277.21
  • Molecular Formula
    C9H13N3O·H3PO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 35mg/mL
  • SMILES
    CC(C)NNC(=O)c1ccncc1.OP(=O)(O)O
  • Chemical Name
    4-Pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide, phosphate (1:1) (9CI)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fagervall I, et al. Biochemical pharmacology, 1986, 35 (8): 1381–7.
molnova catalog
related products
  • A-804598

    A-804598 is a competitive and selective P2X7 receptor antagonist (IC50: 10 nM, rat; 9 nM, mouse; 11 nM, human).

  • Salvigenin

    Salvigenin is a potent hMAO-A inhibitor has neuroprotective antitumor and immunomodulatory effects.

  • Milacemide

    Milacemide is a glycine prodrug and MAO-B inhibitor. Milacemide has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease.